SRTS (Sensus Healthcare, Inc)
Insider Trading Activity
Every open-market purchase and sale reported by SRTS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | Eric Sachetta | Director | Buy | — | — |
| 2026-04-23 | Eric Sachetta | Director | — | — | — |
| 2026-04-22 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | — | — |
| 2026-04-22 | Magdalena Martinez | CHIEF OPERATING OFFICER | F | — | — |
| 2026-02-26 | Eric Sachetta | Director | Buy | — | — |
| 2025-12-16 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | — | — | — |
| 2025-12-16 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | A | — | — |
| 2025-11-21 | Eric Sachetta | Director | Buy | — | — |
| 2025-11-20 | Eric Sachetta | Director | Buy | — | — |
| 2025-11-19 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | — | — |
| 2025-11-19 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2025-11-18 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2025-11-13 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2025-11-12 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2025-08-14 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2025-02-10 | Javier Rampolla | CHIEF FINANCIAL OFFICER | Buy | — | — |
| 2025-02-10 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2024-12-19 | Megan Cornish | Director | A | — | — |
| 2024-12-19 | Anthony Benedict Petrelli | Director | A | — | — |
| 2024-12-19 | William H McCall | Director | A | — | — |
| 2024-12-19 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | A | — | — |
| 2024-07-23 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | — | — |
| 2024-07-23 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | F | — | — |
| 2024-07-17 | William H McCall | Director | Sell | — | — |
| 2024-07-17 | William H McCall | Director | A | — | — |
| 2024-07-17 | William H McCall | Director | J | — | — |
| 2024-05-24 | John Heinrich | Director | Sell | — | — |
| 2024-01-16 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | A | — | — |
| 2023-12-20 | Magdalena Martinez | CHIEF OPERATING OFFICER | F | — | — |
| 2023-09-18 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | — | — |
| 2023-08-28 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2023-08-08 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2023-08-08 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | — | — |
| 2023-07-31 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | — | — |
| 2023-05-31 | John Heinrich | Director | Buy | — | — |
| 2023-05-11 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Buy | — | — |
| 2023-05-10 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Buy | — | — |
| 2023-05-10 | Samuel O'Rear | Director | Buy | — | — |
| 2023-02-03 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | — | — |
| 2023-02-01 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | MIXED | — | — |
| 2022-09-15 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | MIXED | — | — |
| 2022-09-07 | Joseph C Sardano | Chief Executive Officer | Sell | — | — |
| 2022-08-11 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Sell | — | — |
| 2022-08-10 | Samuel O'Rear | Director | Sell | — | — |
| 2022-07-25 | Javier Rampolla | CHIEF FINANCIAL OFFICER | F | — | — |
| 2022-07-25 | Michael Sardano | PRESIDENT AND GENERAL COUNSEL | F | — | — |
| 2022-05-12 | William H McCall | Director | Sell | — | — |
| 2022-03-11 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Sell | — | — |
| 2022-03-10 | Nicolas Soro | CHIEF OPERATING OFFICER | F | — | — |
| 2022-03-10 | Nicolas Soro | CHIEF OPERATING OFFICER | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | CHIEF EXECUTIVE OFFICER | 1,200,293 | — |
| — | EXECUTIVE VICE PRESIDENT | 830,585 | — |
| — | PRESIDENT AND GENERAL COUNSEL | 159,839 | — |
| — | Director | 145,706 | — |
| — | Director | 126,006 | — |
| — | Director | 75,167 | — |
| — | Director | 66,466 | — |
| — | CHIEF FINANCIAL OFFICER | 48,114 | — |
| — | Director | 32,000 | — |
| — | Director | 30,000 | — |
| — | CHIEF OPERATING OFFICER | 12,013 | — |
| — | CHIEF OPERATING OFFICER | 3,546 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SRTS quote page; the site-wide leaderboard is on the insider transactions hub.